Efficacy and safety of pharmacological treatments for restless legs syndrome in hemodialysis patients: a systematic review and meta-analysis - Takeaways - MDSpire

Efficacy and safety of pharmacological treatments for restless legs syndrome in hemodialysis patients: a systematic review and meta-analysis

  • By

  • Juntao Zhang

  • Yuanzhen Huang

  • Jiebao Liang

  • Hua Li

  • May 20, 2026

  • 0 min

Share

  • 1

    Restless Legs Syndrome (RLS) is prevalent in hemodialysis patients, significantly impairing sleep and quality of life.

  • 2

    Pharmacologic therapies, especially gabapentinoids, effectively reduce RLS symptoms and improve sleep quality in hemodialysis patients.

  • 3

    Dopaminergic agents are effective for RLS but are associated with higher adverse event risks, including nausea and hypotension.

  • 4

    Iron therapy provides moderate benefits for RLS in hemodialysis patients with good tolerability and no impact on dialysis adequacy.

  • 5

    High-quality trials on Traditional Chinese Medicine for RLS in hemodialysis are lacking, necessitating rigorous future research.

Original Source(s)

Efficacy and safety of pharmacological treatments for restless legs syndrome in hemodialysis patients: a systematic review and meta-analysis

  • by Juntao Zhang, Yuanzhen Huang, Jiebao Liang, Hua Li

  • May 20, 2026

Related Content

Comparison of vacuum-assisted flexible ureteroscopy and percutaneous nephrolithotomy for 2–3 cm upper tract stones: a real-world cohort study

The role of gut dysbiosis in endocrine and metabolic derangements of chronic kidney disease: mechanisms, controversies, and future perspectives

Prediction models for progression from diabetic kidney disease to end-stage renal disease: a systematic review and meta-analysis